124 related articles for article (PubMed ID: 9485425)
1. Transition-state structure for the ADP-ribosylation of recombinant Gialpha1 subunits by pertussis toxin.
Scheuring J; Berti PJ; Schramm VL
Biochemistry; 1998 Mar; 37(9):2748-58. PubMed ID: 9485425
[TBL] [Abstract][Full Text] [Related]
2. Kinetic isotope effect characterization of the transition state for oxidized nicotinamide adenine dinucleotide hydrolysis by pertussis toxin.
Scheuring J; Schramm VL
Biochemistry; 1997 Apr; 36(15):4526-34. PubMed ID: 9109661
[TBL] [Abstract][Full Text] [Related]
3. Pertussis toxin: transition state analysis for ADP-ribosylation of G-protein peptide alphai3C20.
Scheuring J; Schramm VL
Biochemistry; 1997 Jul; 36(27):8215-23. PubMed ID: 9204866
[TBL] [Abstract][Full Text] [Related]
4. Transition state structure for ADP-ribosylation of eukaryotic elongation factor 2 catalyzed by diphtheria toxin.
Parikh SL; Schramm VL
Biochemistry; 2004 Feb; 43(5):1204-12. PubMed ID: 14756556
[TBL] [Abstract][Full Text] [Related]
5. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
Cyr T; Menzies AJ; Calver J; Whitehouse LW
Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
[TBL] [Abstract][Full Text] [Related]
6. ADP-ribosylation of alpha-Gi proteins by pertussis toxin. Positional dissection of acceptor sites using membrane anchored synthetic peptides.
von Olleschik-Elbheim L; el Bayâ A; Schmidt MA
Methods Mol Biol; 2000; 145():203-17. PubMed ID: 10820724
[No Abstract] [Full Text] [Related]
7. Requirement of ADP-ribosylation for the pertussis toxin-induced alteration in electrophoretic mobility of G-proteins.
Roerig SC; Loh HH; Law PY
Biochem Biophys Res Commun; 1991 Nov; 180(3):1227-32. PubMed ID: 1835388
[TBL] [Abstract][Full Text] [Related]
8. Rapid degradation of NAD by retinoic acid-differentiated HL-60 granulocyte membranes prevents ADP ribosylation.
McLeish KR; Jacobs AA
Biochem Biophys Res Commun; 1993 Apr; 192(2):870-8. PubMed ID: 8387292
[TBL] [Abstract][Full Text] [Related]
9. Induction of adenosine A1 receptor expression by pertussis toxin via an adenosine 5'-diphosphate ribosylation-independent pathway.
Jajoo S; Mukherjea D; Pingle S; Sekino Y; Ramkumar V
J Pharmacol Exp Ther; 2006 Apr; 317(1):1-10. PubMed ID: 16322354
[TBL] [Abstract][Full Text] [Related]
10. Enhanced Gi-protein-mediated mitogenesis following chronic ethanol exposure in a rat model of experimental hepatocellular carcinoma.
McKillop IH; Vyas N; Schmidt CM; Cahill PA; Sitzmann JV
Hepatology; 1999 Feb; 29(2):412-20. PubMed ID: 9918917
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of inhibitory guanine nucleotide regulatory proteins (Gi-proteins) in experimental hepatocellular carcinoma.
McKillop IH; Wu Y; Cahill PA; Sitzmann JV
J Cell Physiol; 1998 Jun; 175(3):295-304. PubMed ID: 9572474
[TBL] [Abstract][Full Text] [Related]
12. ADP-ribosylation activity in pertussis vaccines and its relationship to the in vivo histamine-sensitisation test.
Gomez SR; Yuen CT; Asokanathan C; Douglas-Bardsley A; Corbel MJ; Coote JG; Parton R; Xing DK
Vaccine; 2007 Apr; 25(17):3311-8. PubMed ID: 17287049
[TBL] [Abstract][Full Text] [Related]
13. Crystal structures of pertussis toxin with NAD
Sakari M; Tran MT; Rossjohn J; Pulliainen AT; Beddoe T; Littler DR
J Biol Chem; 2022 May; 298(5):101892. PubMed ID: 35378130
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of ADP-ribosylating bacterial toxins based on oxacarbenium ion character at their transition states.
Zhou GC; Parikh SL; Tyler PC; Evans GB; Furneaux RH; Zubkova OV; Benjes PA; Schramm VL
J Am Chem Soc; 2004 May; 126(18):5690-8. PubMed ID: 15125661
[TBL] [Abstract][Full Text] [Related]
15. Mutation of cysteine 214 in Gi1 alpha subunit abolishes its endogenous GTPase activity.
Wang Y; Tawa G; Smith D; Krishnamurthy G; Young KH
Biochem J; 2004 May; 379(Pt 3):673-9. PubMed ID: 14725508
[TBL] [Abstract][Full Text] [Related]
16. Nucleotide exchange and cGMP phosphodiesterase activation by pertussis toxin inactivated transducin.
Ramdas L; Disher RM; Wensel TG
Biochemistry; 1991 Dec; 30(50):11637-45. PubMed ID: 1661143
[TBL] [Abstract][Full Text] [Related]
17. A proposed mechanism of ADP-ribosylation catalyzed by the pertussis toxin S1 subunit.
Locht C; Antoine R
Biochimie; 1995; 77(5):333-40. PubMed ID: 8527486
[TBL] [Abstract][Full Text] [Related]
18. Fluorescent labeling of signal-transducing G-proteins. Pertussis toxin-catalyzed etheno-ADP ribosylation of transducin.
Hingorani VN; Ho YK
J Biol Chem; 1988 Dec; 263(36):19804-8. PubMed ID: 3143731
[TBL] [Abstract][Full Text] [Related]
19. Pertussis toxin induces structural changes in G alpha proteins independently of ADP-ribosylation.
Ribeiro-Neto FA; Rodbell M
Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2577-81. PubMed ID: 2523074
[TBL] [Abstract][Full Text] [Related]
20. A specific beta gamma-subunit of transducin stimulates ADP-ribosylation of the alpha-subunit by pertussis toxin.
Ohguro H; Fukada Y; Yoshizawa T; Saito T; Akino T
Biochem Biophys Res Commun; 1990 Mar; 167(3):1235-41. PubMed ID: 2322268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
